ClinicalTrials.gg
RecruitingNCT06570681Updated Sep 30, 2026

Video Call Assisted Assessment of Acute Stroke

An interventional study of Video call assisted assessment of acute stroke in Stroke, Cerebrovascular Disorders and Brain Diseases, sponsored by University of Southern Denmark. Recruiting at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-30.

Sponsored by University of Southern Denmark · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Started May 2024; still recruiting 2 years 5 months later.
Updated Sep 30, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
512
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 161 studies in Stroke with a site in Denmark — 29 open to participants now, 45 under way, 4 of them phase 3. Stroke · Denmark.

Planned enrollment
52nd of 113
512 · median 361
Started
2024
with 8 others
No phase
62 of 161
16 open now
Primary completion
2026-12
later than 24 of 44 live
Registered
144th of 161
by date

Among the 161 studies in Stroke with a site in Denmark, this one is the 52nd largest by planned enrollment of the 113 interventional ones that give a count, is one of 9 that started in 2024, is one of 62 with no phase, reaches primary completion later than 24 of the 44 other live ones, and was the 144th registered.

Stroke

8,277 studies on the registry are indexed under Stroke; 2,067 are open to participants now.

Browse Stroke studies →

Open to participants now

29 of the 161 studies in Stroke with a site in Denmark are open now. Recruiting first, the newest first:

23 more — sign in →

All 29 open studies →

A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →

Who these studies take

Of the 1,421 Stroke studies recruiting now, 696 (49%) set no upper age limit and 284 (20%) stop at 75 or younger; 77 take children under 18; 198 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 161 studies in Stroke with a site in Denmark, or all of them as a file.
02

Study summary

This study aims to investigate whether a live stream video between the on-call neurologist and the emergency medical technicians can increase feasibility and performance of symptom-based prehospital stroke scales.

Read the detailed description

Treatment of stroke with either thrombolysis or thrombectomy is highly time-dependent (administration within 4.5 hours and 24 hours from symptom onset, respectively), and morbidity and mortality increase with time from symptom onset to treatment. Hence, prehospital evaluation and transport must be as accurate and rapid as possible in order to minimise time to treatment.

Different triage and transport paradigms for patients with suspected stroke are being investigated and multiple stroke scales have been coined in order to examine patients suspected of stroke in a prehospital setting. However, performance and feasibility vary greatly in different validation studies suggesting that those outcomes are greatly dependent on other factors i.e. acceptance amongst stakeholders, implementation process, patient segment etc. Some recent studies have shown promising results using video solutions between emergency medical services (EMS) personnel and on-call neurologist in examining patients suspected of stroke in the prehospital phase. The investigators will perform this trial to examine whether a video call assisted assessment of patients suspected of stroke in a prehospital setting can increase feasibility and performance of symptom-based prehospital stroke scales.

03

Conditions studied

  • Stroke
  • Cerebrovascular Disorders
  • Brain Diseases
  • Nervous System Diseases
  • Vascular Diseases
  • Central Nervous System Diseases
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Suspected stroke within 24 hours from onset (confirmed with Prehospital Stroke 1 decision tool)
  • Age >18 years

Exclusion criteria

Exclusion Criteria:

  • Suspected stroke more than 24 hours ago
  • In-hospital stroke or private transport to hospital
  • Unconsciousness defined as Glasgow Coma Score (GCS) ≤ 8 (as they cannot be rated)
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
512 participants (estimated)

Study arms

  • No intervention
    Standard Care

    If the patient is eligible for study inclusion, eight symptoms from the study protocol are evaluated and registered in the Prehospital Patient Journal (PPJ) on the amPHITM Prehospital Health Care Record (Amphi Systems, Hasserisvej 125, 9000 Aalborg, Denmark), on a tablet mounted in each EMT vehicle. If the vehicle is in the control arm the patient is triaged by the on-call neurologist based on a standard telephone call

  • Active comparator
    Video call assisted assessment of acute stroke

    If the patient is eligible for study inclusion, the last symptoms from the study protocol are evaluated and registered in the Prehospital Patient Journal (PPJ) on the amPHITM Prehospital Health Care Record (Amphi Systems, Hasserisvej 125, 9000 Aalborg, Denmark), on a tablet mounted in each EMT vehicle. Afterwards the EMS personnel will contact the on-call neurologist and if the vehicle is in the intervention arm a live video stream is initiated. The on-call neurologist then examines the patient via the video-call and triage the patient.

    Diagnostic Test: Video call assisted assessment of acute stroke

Interventions

  • Diagnostic testVideo call assisted assessment of acute stroke

    If the patient is eligible for study inclusion, eight symptoms from the study protocol are evaluated and registered in the Prehospital Patient Journal (PPJ) on the amPHITM Prehospital Health Care Record (Amphi Systems, Hasserisvej 125, 9000 Aalborg, Denmark), on a tablet mounted in each EMT vehicle. Afterwards, the EMS personnel will contact the on-call neurologist and if the vehicle is in the intervention arm a live video stream is initiated. The on-call neurologist then examines the patient via via the video-call and triages the patient.

06

What researchers measure

Primary outcomes

  1. Acute ischemic stroke (AIS) or transient ischemic attack (TIA) diagnosis at discharge

    AIS or TIA as diagnosis. (binary outcome)

    Time frame: At discharge, assessed within one week from symptom onset

Secondary outcomes

  1. Number of patients with acute ischemic stroke (AIS) with LVO on neuroimaging

    AIS with LVO on neuroimaging (computer tomography (CT), CT angiography, magnetic resonance imaging (MRi), MR angiography or catheter-based angiography). LVO is defined as a occlusion or sub-occlusion of the intracranial internal carotid artery, middle cerebral artery M1 or M2, basilar artery. Sign of dense cerebral artery on CT is also considered LVO positive. (binary outcome).

    Time frame: Within 48 hours of admission

  2. Number of patients with Other large vessel AIS

    Neuroimaging (computer tomography (CT), CT angiography, magnetic resonance imaging (MRi), MR angiography or catheter-based angiography) with AIS with occlusion or sub-occlusion of either anterior cerebral artery A1 or A2, posterior cortical artery P1 or intracranial vertebral artery (binary outcome).

    Time frame: at admission

  3. Number of patients with verified acute ischemic stroke (AIS) on neuroimaging

    Neuroimaging (computer tomography (CT), CT angiography, magnetic resonance imaging (MRi), MR angiography or catheter-based angiography) with AIS

    Time frame: Within 48 hours of admission

  4. Number of patients with Haemorrhagic stroke

    Neuroimaging (computer tomography (CT), CT angiography, magnetic resonance imaging (MRi), MR angiography or catheter-based angiography) with intra cranial haemorrhage (ICH) (binary outcome)

    Time frame: at admission

Other outcomes

  1. Duration of examination on video-call

    Duration of examination on video-call measured in minutes (continuous outcome)

    Time frame: up to 120 minutes prior to admission (prehospital phase)

  2. Number of patients which have mimic mistaken for stroke

    Mimic mistaken for stroke evaluated as discrepancy between stroke as tentative diagnoses at primary contact from EMS and final diagnosis at discharge

    Time frame: Through study completion, approximately 2 months

  3. Prehospital time on scene

    Time on scene from arrival EMS to departure EMS measured in minutes (continuous outcome)

    Time frame: up to 120 minutes prior to admission (prehospital phase)

  4. Type of department patient is admitted to after consultation with the neurologist

    Where was the patient sent after telephone/video consultation with the on-call neurologist.

    Time frame: At admission

  5. Door-in-door-out (DIDO) time

    DIDO times for patients subsequently sent to comprehensive stroke unit for thrombectomy treatment.

    Time frame: at admission

  6. Door-to-needle (DNT) time

    DNT times for patients receiving thrombolysis

    Time frame: at admission

  7. Door-to-Groin-Puncture (DTGP) time

    DTGP times for patients receiving treatment with thrombectomy

    Time frame: within 24 hours of admission

  8. Onset-to-Groin-Puncture (OTP) time

    OTP for patients receiving treatment with thrombectomy

    Time frame: within 24 hours of admission

  9. 90 days modified Ranking Scale (mRS)

    Modified Rankin Scale score in stroke patients as evaluated through a structured telephone-based interview performed by a central assessor who is blinded to group assignment

    Time frame: 90 days post admission date

07

Study locations

1 of 1 sites recruiting
  • Department of Neurology
    Aabenraa, Region Syddanmark 6200, Denmark
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2024 (actual). Primary completion is estimated for Dec 2026, 30 months after the start.

Of 3,120 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 30 months is above that.

Counting every sponsor, half of 3,264 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 30, 2026: primary completion Jun 2026 → Dec 2026 and completion Jun 2026 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 28, 2024
First posted
Aug 26, 2024
StartActual
May 27, 2024
Primary completionEst.
Dec 1, 2026was Jun 2026
CompletionEst.
Dec 3, 2026was Jun 2026
Last update
Sep 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jun 1, 2026→Dec 1, 2026
Sep 30, 2026
Study completion
Jun 3, 2026→Dec 3, 2026
Sep 30, 2026
Show all 1 update
  1. Sep 30, 2026
    Primary completion Jun 1, 2026→Dec 1, 2026
    Study completion Jun 3, 2026→Dec 3, 2026

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06570681
Responsible party
Sponsor
First posted
Aug 26, 2024
Start date
May 27, 2024
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 3, 2026 (estimated)
Last update
Sep 30, 2026

Study contacts

Trine Nielsen
Contact
Trine.Nielsen2@rsyd.dk
+45 79 97 00 00
Christian Backer Mogensen
Contact
CBM1@rsyd.dk
+45 79 97 00 00

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion